NovaBridge Biosciences American Depositary Shares
NBP
136 hedge funds and large institutions have $2.38B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.
407% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 14
110% more capital invested
Capital invested by funds: $1.13B → $2.38B (+$1.25B)
70% more funds holding
Funds holding: 80 → 136 (+56)
56% more funds holding in top 10
Funds holding in top 10: 9 → 14 (+5)
45% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 22
6.38% more ownership
Funds ownership: 29.88% → 36.25% (+6.4%)
37% less call options, than puts
Call options by funds: $3.38M | Put options by funds: $5.36M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$108M |
| 2 |
ZAM
Zeal Asset Management
Central,
Hong Kong
|
+$65.2M |
| 3 |
Temasek Holdings
Singapore
|
+$40M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$31.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$39.6M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$27.3M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$25.8M |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$20.4M |
| 5 |
Millennium Management
New York
|
-$20.1M |
NBP Hedge Fund Activity: Q2 2021 in Review
136 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2021, worth a combined $2.38B — up 110% from $1.13B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new NBP positions and 14 closed out — a net gain of 57 holders — while 32 added to existing stakes and 22 trimmed.
The largest buyer was BlackRock, adding an estimated $108M. The largest seller was Avidity Partners Management, cutting an estimated $39.6M.
- 136 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2021, up from 80 in Q1 2021.
- Funds reported $2.38B of NovaBridge Biosciences American Depositary Shares stock for Q2 2021, up 110% quarter-over-quarter.
- 71 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2021 and 14 closed out, a net change of +57 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2021 was BlackRock, an estimated $108M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2021 was Avidity Partners Management, an estimated $39.6M sold.
Based on aggregated 13F filings for Q2 2021.